Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.
Yang R, Elsaadi S, Misund K, Abdollahi P, Vandsemb EN, Moen SH, Kusnierczyk A, Slupphaug G, Standal T, Waage A, Slørdahl TS, Rø TB, Rustad E, Sundan A, Hay C, Cooper Z, Schuller AG, Woessner R, Borodovsky A, Menu E, Børset M, Sponaas AM.
Yang R, et al. Among authors: moen sh.
J Immunother Cancer. 2020 May;8(1):e000610. doi: 10.1136/jitc-2020-000610.
J Immunother Cancer. 2020.
PMID: 32409420
Free PMC article.